Spotlight
Clinical
CME
Partners
2002: Specialists pleased with ongoing retinal progress
Therapies for retinal diseases that re-mained untreatable for decades are seeing major advances. So much so that Jason Slakter, MD, clinical professor of ophthalmology, New York University School of Medicine, and surgeon director, Manhattan Eye, Ear, & Throat Hospital, New York, has proclaimed the first years of the new mil-lennium as the "Decade of the Macula."
Related Videos
Related Content
